Are Allergy Shots Bad For You? Safety Data from 23.3M Injections
No — allergy shots are not bad for you on the population scale. AAAAI/ACAAI surveillance of 23.3 million injection visits (2008–2012) documented 1 confirmed fatality and a stable systemic-reaction rate of 0.1% per visit (Epstein 2014, PMID 23535092). Local reactions occur in 78.3% of patients at least once (LOCAL study, Calabria 2009) but are benign. Uncontrolled asthma is the dominant risk factor for severe reactions.
7 peer-reviewed sources
Allergy shots are not bad for you — surveillance of 23.3 million injections found 1 fatality and a 0.1% systemic-reaction rate per visit. Local arm reactions are common but benign and self-limiting.
The essentials
No — allergy shots are not bad for you on a population level, but giving a quantified answer is more useful than a blanket reassurance. The most comprehensive safety surveillance is Epstein TG et al. (Ann Allergy Asthma Immunol 2013/2014, PMID 23535092/24607043), covering 23.3 million injection visits across the AAAAI/ACAAI network from 2008 to 2012: 1 confirmed fatality across that entire window and a stable systemic-reaction rate of 0.1% per injection visit. The long-run fatality estimate from Bernstein DI et al. (J Allergy Clin Immunol 2004, 12-year survey 1990–2001) is approximately 1 per 2.5 million injections — comparable to or safer than many routine medications.
The "bad for you" framing typically collapses two distinct anxieties: (1) anaphylaxis risk — rare, quantified above — and (2) tolerability of local reactions. Local reactions are the more common story. Per the LOCAL study (Calabria CW, Coop CA, Tankersley MS, J Allergy Clin Immunol 2009;124[4]:739-744, PMID 19767075), 78.3% of patients will develop at least one local reaction across their course; the per-injection local-reaction rate is 16.3%; large local reactions (≥25 mm) occur in just 0.4% of injections (38 of 9,678). These are typically coin-to-palm-sized wheals that itch more than they hurt and resolve within 24 hours — uncomfortable but not dangerous.
Curex offers at-home IgE testing with allergist review so the patient and clinician know which allergens belong in any immunotherapy formulation before the first injection — narrowing the extract list lowers the systemic-reaction risk surface that drives the "are allergy shots bad" question.
The honest caveat: poorly controlled asthma is the dominant risk factor for severe systemic reactions, per Cox 2011 PP3. Epstein 2013 Year 3 surveillance found 86% of US clinics always screen for worsening asthma before every injection. When that pre-injection screen identifies a high-risk day — peak flow down, wheeze present — the standard of care is to postpone that dose. Approximately 70% of severe reactions begin within 30 minutes of the injection, which is why a prescribed epinephrine auto-injector should be confirmed on hand and why the Curex at-home program (curex.com/c/scit-v1) supervises your first dose and every dose change live over Zoom — making safe at-home self-administration possible for eligible maintenance patients while keeping the same gradual escalation and allergist oversight clinics use.
The Cochrane evidence base answers the "good for you" side: Calderón MA et al. (Cochrane 2007, DOI 10.1002/14651858.CD001936.pub2) found a seasonal allergic rhinitis symptom SMD of −0.73 (95% CI −0.97 to −0.50) and medication SMD of −0.57 across 51 RCTs and 2,871 patients. Abramson MJ et al. (Cochrane 2010, DOI 10.1002/14651858.CD001186.pub2) found an NNT of 3 to prevent one patient's asthma deterioration across 88 SCIT trials. In other words, the benefit-risk calculation for appropriately selected patients is strongly favorable.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youSide effects — what to watch for
Allergy shots produce two distinct categories of reactions: local reactions at the injection site (common, benign) and systemic reactions involving areas beyond the injection arm (rare, requiring immediate management). Understanding the difference is essential for patient decision-making.
Frequently asked questions
What is the risk of dying from an allergy shot?
Fatality from allergy shots is extremely rare. The most recent AAAAI/ACAAI surveillance study (Epstein TG et al., Ann Allergy Asthma Immunol 2014, PMID 24607043) documented 1 confirmed fatality across 23.3 million injection visits from 2008–2012. The longer-run estimate from Bernstein DI et al. (J Allergy Clin Immunol 2004, 12-year survey 1990–2001) is approximately 1 fatality per 2.5 million injections, with an average of 3.4 deaths per year across the surveyed period. For context, the fatality risk is comparable to or lower than many commonly prescribed medications. The primary risk mitigation is pre-injection asthma screening plus a confirmed prescribed epinephrine auto-injector and gradual dose escalation; because most reactions begin within 30 minutes, the Curex at-home program supervises your first dose and every dose change live over Zoom, which together intercept the majority of high-risk situations before they escalate.
Who should NOT get allergy shots?
Per Cox L et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55), absolute or strong contraindications to allergy shots include: uncontrolled or severe asthma (FEV1 less than 70% predicted after bronchodilator), concurrent beta-blocker therapy (which impairs epinephrine treatment of anaphylaxis), severe or unstable cardiovascular disease, and significant immunodeficiency. Pregnancy is a contraindication for initiating SCIT (though continuing an established course is generally considered safe). Poorly controlled asthma on the day of injection is the most common reason to delay a dose rather than cancel the course entirely. These decisions are made on a per-visit basis during pre-injection screening.
Are allergy shots safe long-term?
Long-term safety data for allergy shots is reassuring. The AAAAI/ACAAI surveillance program has covered over 23 million injection visits without identifying any cumulative or delayed safety signal beyond the well-characterized per-injection reaction profile. The Cochrane asthma meta-analysis (Abramson MJ et al., Cochrane 2010, DOI 10.1002/14651858.CD001186.pub2, 88 SCIT trials) found that completing the standard 3-5 year course is associated with reduced asthma deterioration risk — meaning the treatment actively improves the long-term disease trajectory. The Durham 1999 NEJM trial demonstrated that discontinuing after 3-4 years does not produce a safety rebound; patients maintained clinical remission for at least 3 further years post-discontinuation. No studies have documented cumulative toxicity from multi-year allergen extract administration.
Does the arm reaction after allergy shots mean something is wrong?
No — a local arm reaction (redness, swelling, itching at the injection site) after an allergy shot typically means the immune system is responding as expected to the allergen extract, not that something has gone wrong. The LOCAL study (Calabria CW, Tankersley MS, J Allergy Clin Immunol 2009, PMID 19767075) found 78.3% of patients develop at least one local reaction across their course, and 16.3% of individual injections produce a noticeable local reaction. In the LOCAL study, a positive predictive value of a local reaction for a subsequent local reaction was only 27.2%, meaning local reactions are not reliably predictive of escalating risk. Small local reactions do not predict systemic reactions. A reaction larger than your palm or persisting more than 24 hours should be reported to the allergist before the next dose.
What is the most dangerous side effect of allergy shots?
The most dangerous potential side effect is systemic anaphylaxis — a body-wide allergic reaction involving throat tightness, difficulty breathing, generalized hives, and cardiovascular collapse. Per WAO grading (Cox L, Larenas-Linnemann D, JACI 2010), grade 3-4 systemic reactions are life-threatening but extremely rare: approximately 1 per million injections for grade-4 events (Epstein 2014, PMID 23535092). Roughly 70% of severe reactions begin within 30 minutes of injection, which is why a prescribed epinephrine auto-injector is confirmed on hand before the first dose and why the Curex at-home program supervises your first injection and every dose change live over Zoom — so your allergist can direct epinephrine treatment in real time. Pre-injection asthma screening is also standard, since patients with poorly controlled asthma are at highest risk. If throat tightness, difficulty breathing, or generalized hives develop, use your epinephrine auto-injector now, call 911, and notify your care team.
Does post-shot fatigue mean the allergy shot is bad for you?
Some patients report mild fatigue within 24 hours after an allergy shot, and this is commonly discussed on patient forums. However, there is currently no peer-reviewed prevalence data for fatigue following conventional aqueous SCIT — the AAAAI/ACAAI surveillance system (Epstein 2014) and the WAO systemic reaction grading system do not capture fatigue as a tracked outcome. Mild transient fatigue, if it occurs, is anecdotally reported but not quantified in the medical literature. It is not classified as a recognized adverse effect in the Cox 2011 PP3 framework. If fatigue after a shot is accompanied by any systemic symptoms — generalized hives, throat tightness, difficulty breathing, lightheadedness — those symptoms should be evaluated as a potential systemic reaction rather than ordinary fatigue.
Are allergy shots bad for your immune system long-term?
No — allergy shots are designed to improve immune function, not damage it. SCIT induces a controlled shift from IgE-mediated Th2 immune overreaction toward regulatory T-cell tolerance, reducing allergen-specific IgE over time while raising IgG4 blocking antibodies. The Cochrane asthma meta-analysis (Abramson MJ et al., Cochrane 2010) found SCIT prevents asthma deterioration. The PAT study (Jacobsen L et al., Allergy 2007; Möller C et al., JACI 2002) showed pediatric SCIT roughly halved new asthma onset at 10-year follow-up — a positive long-term immune outcome. No study has documented immunosuppression, increased infection susceptibility, or adverse immune remodeling from SCIT. The treatment modifies a specific pathological immune response while leaving broader immune competence intact.
Related Articles
Allergy Injections Guide: Schedule & Safety | Curex
Allergy injections (SCIT) mean 60-80+ visits over 3-5 years. Cochrane 51 RCTs: SMD -0.73. Learn what goes in the vial, the schedule, and real-world adherence data.
Read moreWhere Should Allergy Shots Be Given? | Curex Guide
Per Cox 2011 PP3: subcutaneous, upper outer arm, alternating arms, 26-27G needle. Correct technique applies to clinic shots and Curex at-home SCIT.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreWhere To Give Allergy Shots In Arm | Curex Guide
Upper outer arm (posterolateral deltoid), SC, 26-27G, alternating arms. 78.3% get a local reaction. At-home SCIT: Curex $129/mo.
Read moreAllergy Shots for Dog Allergies | Curex Human SCIT Guide
Allergy shots for dog allergies treat HUMANS — not dogs. Dog SCIT evidence is 'poor and conflicting' (Smith 2016). 16.5% of dog-sensitized adults can skip shots entirely.
Read moreWhere To Give Allergy Shots | Curex Allergy Shot Guide
Give allergy shots SC in the upper outer arm (posterolateral deltoid), 26-27G ½-inch, alternating arms. At-home SCIT with Curex at $129/mo.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.